MEX3C and neoplasm: Univariate Cox analysis showed that MEX3C expression (HR: 2.211, 95% CI: 1.233–4.204), gender (HR: 0.053, 95% CI: 0.269–0.942) and tumor stage (HR: 8.291, 95% CI: 1.140-60.306) were independent prognostic factors for HCC patients (Fig. 2C).